Associations between insurance-related affordable care act policy changes with HPV vaccine completion

被引:0
作者
Summer Sherburne Hawkins
Krisztina Horvath
Jessica Cohen
Lydia E. Pace
Christopher F. Baum
机构
[1] Boston College,
[2] School of Social Work,undefined
[3] Boston College,undefined
[4] Department of Economics,undefined
[5] Harvard T.H. Chan School of Public Health,undefined
[6] Department of Global Health and Population,undefined
[7] Brigham and Women’s Hospital,undefined
[8] German Institute for Economic Research (DIW Berlin),undefined
[9] Department of Macroeconomics,undefined
来源
BMC Public Health | / 21卷
关键词
Human papillomavirus; Vaccine; Affordable care act; Policy; Health disparity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 46 条
[1]  
Petrosky E(2011)Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011 MMWR Morb Mortal Wkly Rep 60 1705-1708
[2]  
Bocchini JA(2015)Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices MMWR Morb Mortal Wkly Rep 64 300-304
[3]  
Hariri S(2014)Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature JAMA Pediatr 168 76-82
[4]  
Holman DM(2014)Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systematic review Prev Med 58 22-32
[5]  
Benard V(2018)Parents' uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies BMJ Open 8 757-764
[6]  
Roland KB(2015)ACA provisions associated with increase in percentage of young adult women initiating and completing the HPV vaccine Health Aff (Millwood) 34 23-27
[7]  
Watson M(2018)Human papillomavirus vaccination uptake before and after the affordable care act: variation according to insurance status, race, and education (NHANES 2006-2014) J Pediatr Adolesc Gynecol 31 946-950
[8]  
Liddon N(2018)Predictors of human papillomavirus vaccine follow-through among privately insured US patients Am J Public Health 108 1-8
[9]  
Stokley S(2016)HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US Papillomavirus Res 2 784-792
[10]  
Rambout L(2015)National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2014 MMWR Morb Mortal Wkly Rep 64 65-74